Closure of venous that remained patent from fetal duratio
Phase 3
- Conditions
- Patent Ductus Arteriosus.Persistent ductus arteriosus
- Registration Number
- IRCT201107117010N1
- Lead Sponsor
- Tabriz University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
birth in Alzehra hospital and gestational age equal or lower than 32 week; birth weight equal or between 800-1500g. Exclusion criteria: congenital anomaly; severe asphyxia; thrombocytopenia(plt<50000); creatinine >1.8mg\dl; bleeding tendency; mother consumption of indomethacine.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreasing symptomatic PDA (severity of PDA). Timepoint: 4 days. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method Decreasing assisted ventilation. Timepoint: First 14 days of birth. Method of measurement: Visit.